Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias

Weatherall, D. J.

doi:10.1038/35066048

Cited by 692Hemoglobinopathies and Related DisordersGenetic Associations and EpidemiologyGenomics and Rare Diseases

Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias

Weatherall, D. J.·2001·Nature Reviews Genetics

DOI 10.1038/35066048

Open this paper in CoChat — free account

Abstract

The remarkable phenotypic diversity of the beta-thalassaemias reflects the heterogeneity of mutations at the beta-globin locus, the action of many secondary and tertiary modifiers, and a wide range of environmental factors. It is likely that phenotype-genotype relationships will be equally complex in the case of many monogenic diseases. These findings highlight the problems that might be encountered in defining the relationship between the genome and the environment in multifactorial disorders, in which the degree of heritability might be relatively low and several environmental agents are involved. They also emphasize the value of an understanding of phenotype-genotype relationships in designing approaches to gene therapy.

Integrity signals

Registry

Crossref · 10.1038/35066048

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Patients affected by sickle cell anemia and β-thalassemia experience a milder course of the disease if they express elevated levels of fetal hemoglobin in adulthood.
“Patients affected by sickle cell anemia and β-thalassemia experience a milder course of the disease if they express elevated levels of fetal hemoglobin in adulthood (Platt et al., 1994; Weatherall, 2001).”
From Reactivation of developmentally silenced globin genes by forced chromatin looping (2014) · cites this paper as Weatherall, 2001

The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101 · see citing works
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928 · see citing works
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D. P., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,554 · see citing works
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W. L., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. P. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,166 · see citing works
Pathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154 · cited 1× · see citing works
“At this level of sickleable cells, or above, vaso-occlusive episodes are commo”
Background
The Thalassaemia Syndromes
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,077 · see citing works
Messenger RNA degradation in eukaryotes
Sachs, A. B. (1993) · Cell · doi:10.1016/0092-8674(93)80043-e · Cited by 846 · see citing works
The Thalassæmia Syndromes.
(1973) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 812 · see citing works
Global prevalence of putative haemochromatosis mutations.
Merryweather‐Clarke, A. T., Pointon, J. J., Shearman, J. R., & Robson, K. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.4.275 · Cited by 785 · see citing works
The Molecular Basis of Blood Diseases.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-6-950_3 · Cited by 640 · see citing works
MOLECULAR BASIS FOR MILD FORMS OF HOMOZYGOUS BETA-THALASSAEMIA
Weatherall, D. J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92864-6 · Cited by 485 · see citing works
Iron homeostasis: insights from genetics and animal models
Andrews, N. C. (2000) · Nature Reviews Genetics · doi:10.1038/35042073 · Cited by 418 · see citing works
Binary specification of nonsense codons by splicing and cytoplasmic translation
Thermann, R., Neu‐Yilik, G., Deters, A., Frede, U., Wehr, K., Hagemeier, C., Hentze, M. W., & Kulozik, A. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3484 · Cited by 406 · see citing works
DNA sequence variation associated with elevated fetal G gamma globin production
Gilman, J., & Huisman, T. H. J. (1985) · Blood · doi:10.1182/blood.v66.4.783.783 · Cited by 373 · see citing works
Intron function in the nonsense-mediated decay of β-globin mRNA: Indications that pre-mRNA splicing in the nucleus can influence mRNA translation in the cytoplasm
Zhang, J., Sun, X., Qian, Y., & Maquat, L. E. (1998) · RNA · doi:10.1017/s1355838298971849 · Cited by 306 · see citing works
α + -Thalassemia protects children against disease caused by other infections as well as malaria
Allen, S. J., O’Donnell, A., Alexander, N. D. E., Alpers, M. P., Peto, T., Clegg, J. B., & Weatherall, D. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14736 · Cited by 303 · see citing works
Abnormal RNA processing due to the exon mutation of βE-globin gene
Orkin, S. H., Kazazian, H. H., Antonarakis, S. E., Ostrer, H., Goff, S. C., & Sexton, J. P. (1982) · Nature · doi:10.1038/300768a0 · Cited by 298 · see citing works
Genetic influences on F cells and other hematologic variables: a twin heritability study
Garner, C., Tatu, T., Reittie, J. E., Littlewood, T. J., Darley, J. H., Cervino, S., Farrall, M., Kelly, P. J., Spector, T. D., & Thein, S. L. (2000) · Blood · doi:10.1182/blood.v95.1.342.001k33_342_346 · Cited by 273 · see citing works
Thalassemia — a global public health problem
Weatherall, D. J., & Clegg, J. B. (1996) · Nature Medicine · doi:10.1038/nm0896-847 · Cited by 253 · see citing works
High incidence of malaria in α-thalassaemic children
Williams, T. N., Maitland, K., Bennett, S., Ganczakowski, M., Peto, T., Newbold, C., Bowden, D. K., Weatherall, D. J., & Clegg, J. B. (1996) · Nature · doi:10.1038/383522a0 · Cited by 238 · see citing works
Fetal Hemoglobin Restriction to a Few Erythrocytes (F Cells) in Normal Human Adults
Boyer, S. H., Belding, T. K., Margolet, L., & Noyes, A. N. (1975) · Science · doi:10.1126/science.804182 · Cited by 237 · see citing works
Triplicated alpha-globin loci in humans.
Goossens, M., Dozy, A. M., Embury, S. H., Zachariades, Z., Hadjiminas, M. G., Stamatoyannopoulos, G., & Kan, Y. W. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.518 · Cited by 235 · see citing works
Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients.
Labie, D., Pagnier, J., Lapouméroulie, C., Rouabhi, F., Dunda, O., Chardin, P., Beldjord, C., Wajcman, H., Fabry, M. E., & Nagel, R. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2111 · Cited by 233 · see citing works
A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya.
Fernández-Reyes, D., Craig, A., Kyes, S., Peshu, N., Snow, R. W., Berendt, A., Marsh, K., & Newbold, C. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1357 · Cited by 231 · see citing works
Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2
Dover, G. J., Smith, K. D., Chang, Y., Purvis, S. H., Mays, A. D., Meyers, D. A., Sheils, C. A., & Serjeant, G. R. (1992) · Blood · doi:10.1182/blood.v80.3.816.816 · Cited by 195 · see citing works
Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach
Craig, J. E., Rochette, J., Fisher, C. A., Weatherall, D. J., Marc, S., Lathrop, M. G., Démenais, F., & Thein, S. L. (1996) · Nature Genetics · doi:10.1038/ng0196-58 · Cited by 190 · see citing works
Molecular basis for dominantly inherited inclusion body beta-thalassemia.
Thein, S. L., Hesketh, C., Taylor, P., Temperley, I. J., Hutchinson, R. M., Old, J. M., Wood, W. G., Clegg, J. B., & Weatherall, D. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3924 · Cited by 183 · see citing works
Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States
Gonzalez‐Redondo, J. M., Stoming, T. A., Lanclos, K., Gu, Y., Kutlar, A., Kutlar, F., Nakatsuji, T., Deng, B., Han, I., & McKie, V. C. (1988) · Blood · doi:10.1182/blood.v72.3.1007.1007 · Cited by 174 · see citing works
Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2
Dover, G. J., Smith, K., Chang, Y., et al. (1992) · Blood · doi:10.1182/blood.v80.3.816.bloodjournal803816 · Cited by 168 · see citing works
Baillière's clinical haematology
ScienceDirect (1998) · Cited by 167 · see citing works
Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations
de Silva, S., Fisher, C., Premawardhena, A., Lamabadusuriya, S., Peto, T., Perera, G. K., Old, J., Clegg, J. B., Olivieri, N. F., & Weatherall, D. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08246-x · Cited by 158 · see citing works
A novel α-globin gene arrangement in man
Higgs, D. R., Old, J. M., Pressley, L., Clegg, J. B., & Weatherall, D. J. (1980) · Nature · doi:10.1038/284632a0 · Cited by 152 · see citing works
4 Pathophysiology of thalassaemia
Weatherall, D. J. (1998) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(98)80072-3 · Cited by 150 · see citing works
Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?
Ho, Hall, ., Luo, Weatherall, & Thein (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00519.x · Cited by 142 · see citing works
Self-citation
Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States
Gonzalez‐Redondo, J. M., Stoming, T. A., Lanclos, K., et al. (1988) · Blood · doi:10.1182/blood.v72.3.1007.bloodjournal7231007 · Cited by 139 · see citing works
Beta O-thalassemia intermedia
Cividalli, G., Kerem, H., Ezeckiel, E., & Rachmilewitz, E. A. (1978) · Blood · doi:10.1182/blood.v52.2.345.345 · Cited by 136 · see citing works
A C----T substitution at nt--101 in a conserved DNA sequence of the promotor region of the beta-globin gene is associated with “silent” beta-thalassemia
Gonzalez‐Redondo, J. M., Stoming, T. A., Kutlar, A., Kutlar, F., Lanclos, K., Howard, E., Fei, Y., Aksoy, M., Altay, C., & Gürgey, A. (1989) · Blood · doi:10.1182/blood.v73.6.1705.1705 · Cited by 126 · see citing works
Bone mineral metabolism in adults with β‐thalassaemia major and intermedia
Pollak, R. D., Rachmilewitz, E. A., Blumenfeld, A., Idelson, M., & Goldfarb, A. W. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02392.x · Cited by 126 · see citing works
Mild thalassemia: the result of interactions of alpha and beta thalassemia genes
Kan, Y. W., & Nathan, D. G. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106274 · Cited by 121 · see citing works
The Hemoglobin E Syndromes
Rees, D. C., Styles, L. A., Vichinsky, E. P., Clegg, J. B., & Weatherall, D. J. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10490.x · Cited by 114 · see citing works
Association of thalassaemia intermedia with a beta‐globin gene haplotype
Thein, S. L., Wainscoat, J. S., Sampietro, M., Old, J. M., Cappellini, M. D., Fiorelli, G., Modell, B., & Weatherall, D. J. (1987) · British Journal of Haematology · doi:10.1111/j.1365-2141.1987.tb06870.x · Cited by 114 · see citing works
Identical mutations and phenotypic variation
Wolf, U. (1997) · Human Genetics · doi:10.1007/s004390050509 · Cited by 106 · see citing works
BONE DISEASE IN β‐THALASSAEMIA MAJOR
Wonke (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01107.x · Cited by 98 · see citing works
The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous β‐thalassaemia and in glucose‐6‐phosphate dehydrogenase deficiency
Sampietro, M., Lupica, L., Perrero, L., Comino, A., di Montemuros, F. M., Cappellini, M. D., & Fiorelli, G. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4113228.x · Cited by 98 · see citing works
DOMINANT β THALASSAEMIA: MOLECULAR BASIS AND PATHOPHYSIOLOGY
Thein, S. L. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb08132.x · Cited by 95 · see citing works
Haemochromatosis in patients with β‐thalassaemia trait
Piperno, A., Mariani, R., Arosio, C., Vergani, A., Bosio, S., Fargion, S., Sampietro, M., Girelli, D., Fraquelli, M., Conte, D., et al. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02436.x · Cited by 91 · see citing works
A family with segregating triplicated alpha globin loci and beta thalassemia
Galanello, R., Ruggeri, R., Paglietti, E., Addis, M., Melis, M., & Cao, A. (1983) · Blood · doi:10.1182/blood.v62.5.1035.1035 · Cited by 90 · see citing works
A Genetically Determined Disorder with Features both of Thalassaemia and Congenital Dyserythropoietic Anaemia
Weatherall, D. J., Clegg, J. B., Knox-Macaulay, H., Bunch, C., Hopkins, C. R., & Temperley, I. J. (1973) · British Journal of Haematology · doi:10.1111/j.1365-2141.1973.tb01696.x · Cited by 89 · see citing works
The Silent Carrier of Beta Thalassemia
Schwartz, E. (1969) · New England Journal of Medicine · doi:10.1056/nejm196912112812403 · Cited by 87 · see citing works
Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background
Perrotta, S., Cappellini, M. D., Bertoldo, F., Servedio, V., Iolascon, G., D’Agruma, L., Gasparini, P., Siciliani, M. C., & Iolascon, A. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02382.x · Cited by 79 · see citing works
β + Thalassaemia—Portuguese type: clinical, haematological and molecular studies of a newly defined form of β thalassaemia
Tamagnini, G. P., Lopes, M. C., Castanheira, M., Wainscoat, J. S., & Wood, W. G. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.00189.x · Cited by 77 · see citing works
Hyperbilirubinaemia in heterozygous β‐thalassaemia is related to co‐inherited Gilbert's syndrome
Galanello, R., Perseu, L., Melis, M., Cipollina, L., Barella, S., Giagu, N., Turco, M., Maccioni, O., & Cao, A. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.3703182.x · Cited by 71 · see citing works
Molecular analysis of beta zero-thalassemia intermedia in Sardinia
Galanello, R., Dessi, E., Melis, M., Addis, M., Sanna, M., Rosatelli, M. C., Argiolu, F., Giagu, N., Turco, M., & Cacace, E. (1989) · Blood · doi:10.1182/blood.v74.2.823.823 · Cited by 66 · see citing works
IS IT DOMINANTLY INHERITED β THALASSAEMIA OR JUST A β‐CHAIN VARIANT THAT IS HIGHLY UNSTABLE?
Thein, S. L. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01492.x · Cited by 65 · see citing works
From genotype to phenotype: genetics and medical practice in the new millennium
Weatherall, D. J. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0539 · Cited by 58 · see citing works
Inclusion-Body β-Thalassemia Trait
Stamatoyannopoulos, G., Woodson, R. D., PAPAYANNOPOULOU, T., Heywood, D., & Kurachi, S. (1974) · New England Journal of Medicine · doi:10.1056/nejm197404252901705 · Cited by 58 · see citing works
Thalassemia in the Next Millennium: Keynote Addressa
Weatherall, D. J. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10456.x · Cited by 58 · see citing works
Why Are Hemoglobin F Levels Increased in HbE/β Thalassemia?
Rees, D. C., Porter, J. B., Clegg, J. B., & Weatherall, D. J. (1999) · Blood · doi:10.1182/blood.v94.9.3199 · Cited by 55 · see citing works
The triplicated α gene locus and β thalassaemia
Kanavakis, E., Metaxotou-Mavromati, A., Kattamis, C., Wainscoat, J. S., & Wood, W. G. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.00201.x · Cited by 54 · see citing works
Erythroblastic Inclusions in Dominantly Inherited β Thalassemias
Ho, P. J., Wickramasinghe, S. N., Rees, D. C., Lee, M. J., Eden, A., & Thein, S. L. (1997) · Blood · doi:10.1182/blood.v89.1.322 · Cited by 51 · see citing works
The triplicated α gene locus and β thalassaemia
Kanavakis, E., Metaxotou-Mavromati, A., Kattamis, C., et al. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.tb02088.x · Cited by 48 · see citing works
The Clinical and Biosynthetic Characterization of αβ‐Thalassaemia
Knox-Macaulay, H., Weatherall, D. J., Clegg, J. B., Bradley, J., & Brown, M. J. (1972) · British Journal of Haematology · doi:10.1111/j.1365-2141.1972.tb05695.x · Cited by 47 · see citing works
Silent thalassemias: genotypes and phenotypes.
Bianco, I., Cappabianca, M. P., Foglietta, E., Lerone, M., Deidda, G., Morlupi, L., Grisanti, P., Ponzini, D., Rinaldi, S., & Graziani, B. (1997) · PubMed · Cited by 47 · see citing works
Genetic heterogeneity in heterocellular hereditary persistence of fetal hemoglobin.
Craig, J. E., Rochette, J., Sampietro, M., Wilkie, A. O. M., Barnetson, R., Hatton, C. S. R., Démenais, F., & Thein, S. L. (1997) · PubMed · doi:10.1182/blood.v90.1.428 · Cited by 43 · see citing works
The Role of Genomics in Studying Genetic Susceptibility to Infectious Disease: Figure 1.Preprint
Weatherall, D. J., Clegg, J. B., & Kwiatkowski, D. P. (1997) · Genome Research · doi:10.1101/gr.7.10.967 · Cited by 43 · see citing works
β+Thalassaemia—Portuguese type: clinical, haematological and molecular studies of a newly defined form of β thalassaemia
Tamagnini, G. P., Lopes, M. C., Castanheira, M., et al. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.tb02087.x · Cited by 43 · see citing works
Inherited thrombotic disorders: An update
Florell, S. R., & Rodgers, G. M. (1997) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199701)54:1 · Cited by 41 · see citing works
Is Hemoglobin Instability Important in the Interaction Between Hemoglobin E and β Thalassemia?
Rees, D. C., Clegg, J. B., & Weatherall, D. J. (1998) · Blood · doi:10.1182/blood.v92.6.2141 · Cited by 38 · see citing works
Thalassaemia intermedia
Wainscoat, J. S., Thein, S. L., & Weatherall, D. J. (1987) · Blood Reviews · doi:10.1016/0268-960x(87)90029-4 · Cited by 29 · see citing works
Possible factors influencing the haemoglobin and fetal haemoglobin levels in patients with β‐thalassaemia due to a homozygosity for the IVS‐I‐6 (T→C) mutation
Efremov, D. G., Dimovski, A. J., BAYSAL, E., Ye, Z., Adekile, A. D., Ribeiro, M. L., Schilirò, G., Altay, Ç., Gürgey, A., Ефремов, Г. Д., et al. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04837.x · Cited by 26 · see citing works
Severe inclusion body β‐thalassaemia with haemolysis in a patient double heterozygous for β°‐thalassaemia and quadruplicated α‐globin gene arrangement of the anti‐4.2 type
Beris, P., Solenthaler, M., Deutsch, S., Darbellay, R., Tobler, A., Bochaton‐Piallat, M., & Gabbiani, G. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01451.x · Cited by 22 · see citing works
Nontransfusional Iron Overload in Thalassemia: Association with Hereditary Hemochromatosis
Rees, D. C., Singh, B. M., Luo, L., Wickramasinghe, S. N., & Thein, S. L. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10530.x · Cited by 21 · see citing works
Effect of pyrexia in the formation of intraerythrocytic inclusion bodies and vacuoles in haemolytic crisis of haemoglobin H disease
Chinprasertsuk, S., Wanachiwanawin, W., & Piankijagum, A. (1994) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1994.tb01291.x · Cited by 18 · see citing works
The Interaction of Anti 3. 7 Type Quadruplicated α-Globin Genes and Heterozygous β-Thalassemia
Thompson, C. C., Ali, M., Vacovsky, M., & Boyadjian, S. (1989) · Hemoglobin · doi:10.3109/03630268908998062 · Cited by 15 · see citing works
Molecular pathology of thalassemia intermedia
Cao, A., Gasperini, D., Podda, A. S., & Galanello, R. (1990) · European Journal of Internal Medicine · Cited by 12 · see citing works
THE CLINICAL AND MOLECULAR HETEROGENEITY OF THE THALASSEMIA SYNDROMES *
Weatherall, D. J., Clegg, J. B., Wood, W. G., Old, J. M., Higgs, D. R., Pressley, L., & Darbre, P. D. (1980) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1980.tb33652.x · Cited by 10 · see citing works
Gene therapy: Repairing haemoglobin disorders with ribozymes
Weatherall, D. J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70439-7 · Cited by 8 · see citing works
Hemoglobin E/β Thalassemia: The Canadian Experience
Fouladi, M., MacMillan, M. L., Nisbet‐Brown, E., KLEIN, N., Barlas, J., Waye, J. S., & Olivieri, N. F. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10506.x · Cited by 8 · see citing works
β+-Thalassemia Intermedia
Philip, T. O., Souillet, G., Philippe, N., Freycon, F., Bektas, S., Morlé, L., Trabuchet, G., & Godet, J. (1980) · Human Heredity · doi:10.1159/000153151 · Cited by 6 · see citing works
The Silent Carrier of β‐Thalassemia
Sciarratta, G. V., Parodi, M. I., Agosti-Vallerino, S., & Sansone, G. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb17180.x · Cited by 6 · see citing works
Clinical features of thalassemia intermedia in Italy.
Fiorelli, G., Sampietro, M., Romano, M., Albano, M., & Cappellini (1987) · PubMed · Cited by 6 · see citing works
Genetic influences on bone disease in thalassemia.
Basran, R. K., Rees, D. C., Hum, B., Yiu, S. C., Peto, T., Weatherall, D. J., & Olivieri, N. F. (1998) · Blood · Cited by 4 · see citing works
Untitled work
(1996) · doi:10.1002/(sici)1098-1004(1996)7:4

Flagged first, then by citations

Sorted by citations

Sickle-cell disease
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504 · see citing works
The muscular dystrophies
Emery, A. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07815-7 · Cited by 1,667 · see citing works
β-Thalassemia
Rund, D. G., & Rachmilewitz, E. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 936 · see citing works
Understanding quantitative genetic variation
Barton, N., & Keightley, P. D. (2002) · Nature Reviews Genetics · doi:10.1038/nrg700 · Cited by 839 · see citing works
Beta-thalassemia
Cao, A., & Galanello, R. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd68ed · Cited by 722 · see citing works
Identifying Signatures of Natural Selection in Tibetan and Andean Populations Using Dense Genome Scan Data
Bigham, A., Bauchet, M., Pinto, D., Mao, X., Akey, J. M., Mei, R., Scherer, S. W., Julian, C. G., Wilson, M. J., López Herráez, D., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001116 · Cited by 597 · see citing works
L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy
Oudit, G. Y., Sun, H., Trivieri, M. G., Koch, S. E., Dawood, F., Ackerley, C., Yazdanpanah, M., Wilson, G. J., Schwartz, A., Liu, P. P., et al. (2003) · Nature Medicine · doi:10.1038/nm920 · Cited by 480 · see citing works
Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell Disease
Esrick, E. B., Lehmann, L. E., Biffi, A., Achebe, M., Brendel, C., Ciuculescu, M. F., Daley, H., MacKinnon, B., Morris, E., Federico, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029392 · Cited by 449 · see citing works
Reactivation of developmentally silenced globin genes by forced chromatin looping
Deng, W., Rupon, J. W., Krivega, I., Breda, L., Motta, I., Jahn, K. S., Reik, A., Gregory, P. D., Rivella, S., Dean, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.050 · Cited by 443 · see citing works
Genetics of susceptibitlity to human infectious disease
Cooke, G., & Hill, A. V. S. (2001) · Nature Reviews Genetics · doi:10.1038/35103577 · Cited by 444 · see citing works
Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells
Tanno, T., Porayette, P., Sripichai, O., Noh, S.-J., Byrnes, C., Bhupatiraju, A., Lee, Y. T., Goodnough, J. B., Harandi, O., Ganz, T., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195503 · Cited by 352 · see citing works
The switch from fetal to adult hemoglobin.
Sankaran, V. G., & Orkin, S. H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011643 · Cited by 333 · see citing works
Recombinant pharmaceuticals from microbial cells: a 2015 update
Sánchez‐García, L., Martín, L., Mangues, R., Ferrer‐Miralles, N., Vázquez, E., & Villaverde, A. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0437-3 · Cited by 341 · see citing works
Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis
Moore, J. H., & Williams, S. M. (2005) · BioEssays · doi:10.1002/bies.20236 · Cited by 340 · see citing works
Changing patterns in the epidemiology of β‐thalassemia
Kattamis, A., Forni, G. L., Aydınok, Y., & Viprakasit, V. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13512 · Cited by 332 · see citing works
The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening
Xu, X., Zhou, Y., Luo, G., Liao, C., Zhou, M., Chen, P. Y., Lu, J., Jia, S., Xiao, G. F., Shen, X., et al. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014456 · Cited by 326 · see citing works
Robustness, evolvability, and neutrality
Wagner, A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.063 · Cited by 317 · see citing works
Thalassemia intermedia: Revisited
Taher, A. T., Isma’eel, H., & Cappellini, M. D. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.04.005 · Cited by 319 · see citing works
Hemoglobin H disease: not necessarily a benign disorder
Chui, D. H. K., Fucharoen, S., & Chan, V. (2003) · Blood · doi:10.1182/blood-2002-07-1975 · Cited by 309 · see citing works
Social Adversity, the Serotonin Transporter (5-HTTLPR) Polymorphism and Major Depressive Disorder
Surtees, P. G., Wainwright, N. W. J., Willis-Owen, S. A. G., Luben, R., Day, N. E., & Flint, J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.014 · Cited by 265 · see citing works
Is there a future for TNF promoter polymorphisms?
Bayley, J.-P., Ottenhoff, T. H. M., & Verweij, C. L. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364055 · Cited by 265 · see citing works
3′ end mRNA processing: molecular mechanisms and implications for health and disease
Danckwardt, S., Hentze, M. W., & Kulozik, A. E. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601932 · Cited by 296 · see citing works
Control of fetal hemoglobin: new insights emerging from genomics and clinical implications
Thein, S. L., Menzel, S., Lathrop, M., & Garner, C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp401 · Cited by 250 · see citing works
Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem
Vogiatzi, M. G., Macklin, E. A., Fung, E. B., Cheung, A. M., Vichinsky, E. P., Olivieri, N. F., Kirby-Allen, M. A., Kwiatkowski, J. L., Cunningham, M. J., Holm, I. A., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080505 · Cited by 254 · see citing works
Population Stratification of a Common APOBEC Gene Deletion Polymorphism
Kidd, J. M., Newman, T. L., Tüzün, E., Kaul, R., & Eichler, E. E. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030063 · Cited by 246 · see citing works
Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China
Xiong, F., Sun, M., Zhang, X., Cai, R., Zhou, Y., Lou, J., Zeng, L., Sun, Q., Xiao, Q., Shang, X., et al. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01430.x · Cited by 248 · see citing works
Mendelian disorders deserve more attention
Antonarakis, S. E., & Beckmann, J. S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1826 · Cited by 241 · see citing works
Challenges of blood transfusions in β-thalassemia
Shah, F., Sayani, F. A., Trompeter, S., Drašar, E., & Piga, A. G. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100588 · Cited by 236 · see citing works
Race, ancestry, and genes: implications for defining disease risk.
Kittles, R., & Weiss, K. (2003) · Annual review of genomics and human genetics (Print) · doi:10.1146/annurev.genom.4.070802.110356 · Cited by 229 · see citing works
Patterns of Human Diversity, within and among Continents, Inferred from Biallelic DNA PolymorphismsPreprint
Romualdi, C., Balding, D. J., Nasidze, I. S., Risch, G., Robichaux, M. B., Sherry, S. T., Stoneking, M., Batzer, M. A., & Barbujani, G. (2002) · Genome Research · doi:10.1101/gr.214902 · Cited by 226 · see citing works
X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction
Yu, C., Niakan, K. K., Matsushita, M. M., Stamatoyannopoulos, G., Orkin, S. H., & Raskind, W. H. (2002) · Blood · doi:10.1182/blood-2002-02-0387 · Cited by 217 · see citing works
A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
Rivella, S., May, C., Chadburn, A., Rivière, I., & Sadelain, M. (2003) · Blood · doi:10.1182/blood-2002-10-3305 · Cited by 220 · see citing works
Genotype–Phenotype Correlations in Autosomal Dominant and Autosomal Recessive Polycystic Kidney Disease
Rossetti, S., & Harris, P. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010125 · Cited by 215 · see citing works
Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities
Wilber, A. C., Nienhuis, A. W., & Persons, D. A. (2011) · Blood · doi:10.1182/blood-2010-11-316893 · Cited by 217 · see citing works
Advances in the understanding of haemoglobin switching
Sankaran, V. G., Xu, J., & Orkin, S. H. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08105.x · Cited by 216 · see citing works
Predicting disease using genomics
Bell, J. I. (2004) · Nature · doi:10.1038/nature02624 · Cited by 214 · see citing works
Optimal management of β thalassaemia intermedia
Taher, A. T., Musallam, K. M., Cappellini, M. D., & Weatherall, D. J. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08486.x · Cited by 207 · see citing works
Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
Ye, L., Wang, J., Tan, Y., Beyer, A. I., Xie, F., Muench, M. O., & Kan, Y. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612075113 · Cited by 190 · see citing works
A genetic profile of contemporary Jewish populations
D, H. O. M. (2001) · Nature Reviews Genetics · doi:10.1038/35098506 · Cited by 185 · see citing works
Pathophysiology and Clinical Manifestations of the -ThalassemiasPreprint
Nienhuis, A. W., & Nathan, D. G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011726 · Cited by 180 · see citing works
Sickle Cell Disease: New Opportunities and Challenges in Africa
Makani, J., Ofori-Acquah, S. F., Nnodu, O. E., Wonkam, A., & Ohene‐Frempong, K. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/193252 · Cited by 177 · see citing works
Maneuvering in the Complex Path from Genotype to Phenotype
Strohman, R. C. (2002) · Science · doi:10.1126/science.1070534 · Cited by 176 · see citing works
Krüppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants
Perkins, A. C., Xu, X., Higgs, D. R., Patrinos, G. P., Arnaud, L., Bieker, J. J., Philipsen, S., & Workgroup, T. K. C. (2016) · Blood · doi:10.1182/blood-2016-01-694331 · Cited by 165 · see citing works
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia
Libani, I. V., Guy, E. C., Melchiori, L., Schirò, R., Ramos, P., Breda, L., Scholzen, T. E., Chadburn, A., Liu, Y., Kernbach, M., et al. (2008) · Blood · doi:10.1182/blood-2007-12-126938 · Cited by 162 · see citing works
Cilia in vertebrate development and disease
Oh, E. C. T., & Katsanis, N. (2012) · Development · doi:10.1242/dev.050054 · Cited by 158 · see citing works
Genetic Variation and Adaptation in Africa: Implications for Human Evolution and DiseasePreprint
Gomez, F., Hirbo, J. B., & Tishkoff, S. A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008524 · Cited by 160 · see citing works
A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation
Borgatti, R., Zucca, C., Cavallini, A. R., Ferrario, M., Panzeri, C., Castaldo, P., Soldovieri, M. V., Baschirotto, C., Bresolin, N., Bernardina, B. D., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000132979.08394.6d · Cited by 156 · see citing works
Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia
Kong, Y., Zhou, S., Kihm, A. J., Katein, A. M., Yu, X., Gell, D. A., Mackay, J. P., Adachi, K., Foster-Brown, L., Louden, C. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21982 · Cited by 156 · see citing works
KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia
Liu, D., Zhang, X., Yu, L., Cai, R., Ma, X., Zheng, C., Zhou, Y., Liu, Q., Wei, X., Lin, L., et al. (2014) · Blood · doi:10.1182/blood-2014-03-561779 · Cited by 155 · see citing works
Improved Hematopoietic Differentiation Efficiency of Gene-Corrected Beta-Thalassemia Induced Pluripotent Stem Cells by CRISPR/Cas9 System
Song, B., Fan, Y., He, W., Zhu, D., Niu, X., Wang, D., Ou, Z., Luo, M., & Sun, X. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0347 · Cited by 154 · see citing works
Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
Xu, P., Tong, Y., Liu, X., Wang, T., Li, C., Wang, B.-Y., Lv, X., Huang, Y., & Liu, D. (2015) · Scientific Reports · doi:10.1038/srep12065 · Cited by 150 · see citing works
Edgotype: a fundamental link between genotype and phenotype
Sahni, N., Yi, S. S., Zhong, Q., Jailkhani, N., Charloteaux, B., Cusick, M. E., & Vidal, M. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.002 · Cited by 147 · see citing works
Molecular Basis and Genetic Modifiers of Thalassemia
Mettananda, S., & Higgs, D. R. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.003 · Cited by 147 · see citing works
Screening for thalassemia
Cao, A., Rosatelli, M. C., Monni, G., & Galanello, R. (2002) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(01)00006-7 · Cited by 146 · see citing works
Ineffective Erythropoiesis in β ‐Thalassemia
Ribeil, J., Arlet, J., Dussiot, M., Moura, I. C., Courtois, G., & Hermine, O. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/394295 · Cited by 141 · see citing works
Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids
Kalpravidh, R. W., Siritanaratkul, N., Insain, P., Charoensakdi, R., Panichkul, N., Hatairaktham, S., Srichairatanakool, S., Phisalaphong, C., Rachmilewitz, E. A., & Fucharoen, S. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.10.057 · Cited by 136 · see citing works
-Thalassemia Intermedia: A Clinical PerspectivePreprint
Musallam, K. M., Taher, A. T., & Rachmilewitz, E. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013482 · Cited by 132 · see citing works
Changes in the Epidemiology of Thalassemia in North America: A New Minority Disease
Vichinsky, E. P., Macklin, E. A., Waye, J. S., Lorey, F., & Olivieri, N. F. (2005) · PEDIATRICS · doi:10.1542/peds.2005-0843 · Cited by 131 · see citing works
Sickle Cell Disease
Buchanan, G. R., DeBaun, M. R., Quinn, C. T., & Steinberg, M. H. (2004) · Hematology · doi:10.1182/asheducation-2004.1.35 · Cited by 129 · see citing works
Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance
Carta, S., Penco, F., Lavieri, R., Martini, A., Dinarello, C. A., Gattorno, M., & Rubartelli, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424741112 · Cited by 121 · see citing works
Adducin Polymorphism
Bianchi, G., Ferrari, P., & Staessen, J. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000156497.39375.37 · Cited by 124 · see citing works
Prevention of severe thalassemia in northeast Thailand: 16 years of experience at a single university center
Yamsri, S., Sanchaisuriya, K., Fucharoen, G., Sae‐ung, N., Ratanasiri, T., & Fucharoen, S. (2010) · Prenatal Diagnosis · doi:10.1002/pd.2514 · Cited by 124 · see citing works
Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids
Aouizerat, B. E., Kulkarni, M. V., Heilbron, D. C., Drown, D. J., Raskin, S., Pullinger, C. R., Malloy, M. J., & Kane, J. P. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200480-jlr200 · Cited by 118 · see citing works
Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies
Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114 · see citing works
Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis
Winge, M. C. G., Bilcha, K. D., Liedén, A., Shibeshi, D., Sandilands, A., Wahlgren, C., McLean, W. H. I., Nordenskjöld, M., & Bradley, M. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10475.x · Cited by 116 · see citing works
Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneity
Orfali, K. A., Ohene‐Abuakwa, Y., & Ball, S. E. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04890.x · Cited by 116 · see citing works
A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease
Cai, L., Bai, H., Mahairaki, V., Gao, Y., He, C., Wen, Y., Jin, Y.-C., Wang, Y., Pan, R. L., Qasba, A., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0066 · Cited by 109 · see citing works
Studies in haemoglobin E beta‐thalassaemia
Olivieri, N. F., Muraca, G. M., O’Donnell, A., Premawardhena, A., Fisher, C. A., & Weatherall, D. J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07126.x · Cited by 109 · see citing works
Update in the genetics of thalassemia: What clinicians need to know
Shang, X., & Xu, X. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.10.012 · Cited by 106 · see citing works
Erythrocyte variants and the nature of their malaria protective effect
Min‐Oo, G., & Gros, P. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00524.x · Cited by 106 · see citing works
Muscular dystrophy into the new millennium
Emery, A. E. H. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00303-0 · Cited by 106 · see citing works
Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with β thalassemia
Viprakasit, V., Tanphaichitr, V. S., Chinchang, W., Sangkla, P., Weiss, M. J., & Higgs, D. R. (2004) · Blood · doi:10.1182/blood-2003-11-3957 · Cited by 105 · see citing works
Heme-regulated eIF2α kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and β-thalassemia
Han, A., Fleming, M. D., & Chen, J.-J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24141 · Cited by 104 · see citing works
Susceptibility to malaria as a complex trait: big pressure from a tiny creature
Fortin, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2469 · Cited by 104 · see citing works
Beyond the Oncogene Paradigm: Understanding Complexity in Cancerogenesis
Bizzarri, M., Cucina, A., Conti, F., & D’Anselmi, F. (2008) · Acta Biotheoretica · doi:10.1007/s10441-008-9047-8 · Cited by 102 · see citing works
α‐Thalassemia: Hb H Disease and Hb Barts Hydrops Fetalis
Chui, D. H. K. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.004 · Cited by 100 · see citing works
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer
Wilber, A. C., Hargrove, P. W., Kim, Y., Riberdy, J. M., Sankaran, V. G., Papanikolaou, E., Georgomanoli, M., Anagnou, N. P., Orkin, S. H., Nienhuis, A. W., et al. (2010) · Blood · doi:10.1182/blood-2010-08-300723 · Cited by 98 · see citing works
Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease
Ernst, M. P. T., Broeders, M., Herrero-Hernandez, P., Oussoren, E., van der Ploeg, A. T., & Pijnappel, W. W. M. P. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.022 · Cited by 99 · see citing works
Single-Tube Multiplex-PCR Screen for Anti-3.7 and Anti-4.2 α-Globin Gene Triplications
Wang, W., Ma, E. S. K., Chan, A. Y. Y., Prior, J. F., Erber, W. N., Chan, L. C., Chui, D. H. K., & Chong, S. S. (2003) · Clinical Chemistry · doi:10.1373/49.10.1679 · Cited by 99 · see citing works
Targeted Therapeutic Strategies for Fetal Hemoglobin Induction
Sankaran, V. G. (2011) · Hematology · doi:10.1182/asheducation-2011.1.459 · Cited by 97 · see citing works
Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia
Gardenghi, S., Grady, R. W., & Rivella, S. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.003 · Cited by 96 · see citing works
The hydration state of human red blood cells and their susceptibility to invasion by Plasmodium falciparum
Tiffert, T., Lew, V. L., Ginsburg, H., Krugliak, M., Croisille, L., & Mohandas, N. (2005) · Blood · doi:10.1182/blood-2004-12-4948 · Cited by 91 · see citing works
Haemoglobin C and S Role in Acquired Immunity against Plasmodium falciparum Malaria
Verra, F., Simporè, J., Warimwe, G. M., Tetteh, K. K. A., Howard, T., Osier, F. H. A., Bancone, G., Avellino, P., Blot, I., Fegan, G., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000978 · Cited by 88 · see citing works
Population Screening for Hemoglobinopathies
Goonasekera, H. W. W., Paththinige, C. S., & Dissanayake, V. H. W. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091416-035451 · Cited by 87 · see citing works
The Present and Future Global Burden of the Inherited Disorders of Hemoglobin
Piel, F. B. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.11.004 · Cited by 87 · see citing works
Determinants of the Development of Diabetes (Maturity-Onset Diabetes of the Young-3) in Carriers of HNF-1α Mutations
Klupa, T., Warram, J. H., Antonellis, A., Pezzolesi, M. G., Nam, M., Malecki, M. T., Doria, A., Rich, S. S., & Królewski, A. S. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2292 · Cited by 87 · see citing works
Base and Prime Editing Technologies for Blood Disorders
Antoniou, P., Miccio, A., & Brusson, M. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618406 · Cited by 86 · see citing works
The proteomic landscape of genome-wide genetic perturbations
Messner, C. B., Demichev, V., Muenzner, J., Aulakh, S. K., Barthel, N., Röhl, A., Herrera-Domínguez, L., Egger, A.-S., Kamrad, S., Hou, J., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.026 · Cited by 84 · see citing works
A case for developing North-South partnerships for research in sickle cell disease
Weatherall, D. J., Hofman, K. J., Rodgers, G. P., Ruffin, J., & Hrynkow, S. H. (2004) · Blood · doi:10.1182/blood-2004-06-2404 · Cited by 85 · see citing works
Imprinting of Genes and the Barker Hypothesis
Young, L. E. (2001) · Twin Research · doi:10.1375/1369052012632 · Cited by 84 · see citing works
Thalassaemia: the long road from bedside to genome
Weatherall, D. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1406 · Cited by 81 · see citing works
The Thalassemias: The Role of Molecular Genetics in an Evolving Global Health Problem**Previously presented at the annual meeting of The American Society of Human Genetics, in Los Angeles, on November 7, 2003.
Weatherall, D. J. (2004) · The American Journal of Human Genetics · doi:10.1086/381402 · Cited by 81 · see citing works
Mendelian disorders and multifactorial traits: the big divide or one for all?
Antonarakis, S. E., Chakravarti, A., Cohen, J. C., & Hardy, J. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2793 · Cited by 80 · see citing works
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia
Fisher, S. A., Brunskill, S. J., Doree, C. J., Gooding, S., Chowdhury, O., & Roberts, D. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004450.pub3 · Cited by 78 · see citing works
Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression
Antoniou, P., Hardouin, G., Martinucci, P., Frati, G., Félix, T., Chalumeau, A., Fontana, L., Martin, J., Masson, C., Brusson, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34493-1 · Cited by 81 · see citing works
Molecular Basis and Genetic Modifiers of Thalassemia
Tesio, N., & Bauer, D. E. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.001 · Cited by 83 · see citing works
Guidelines for Diagnosis and Management of Beta-Thalassemia Intermedia
Karimi, M., Cohan, N., Sanctis, V. D., Mallat, N. S., & Taher, A. T. (2014) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2014.937884 · Cited by 78 · see citing works
Exploring genetic modifiers of Gaucher disease: The next horizon
Davidson, B. A., Hassan, S., Garcia, E. J., Tayebi, N., & Sidransky, E. (2018) · Human Mutation · doi:10.1002/humu.23611 · Cited by 78 · see citing works
Complex genetic control of susceptibility to malaria in mice
Fortin, A., Stevenson, M. M., & Gros, P. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363841 · Cited by 78 · see citing works
Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus
Min‐Oo, G., Fortin, A., Pitari, G., Tam, M., Stevenson, M. M., & Gros, P. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061252 · Cited by 77 · see citing works

Authors: Weatherall, D. J.
Affiliations: John Radcliffe Hospital (GB)
Corresponding author: Weatherall, D. J.
Venue: Nature Reviews Genetics
Publisher: Springer Science and Business Media LLC
Published: 2001-04
Volume: 2
Issue: 4
Pages: 245-255
ISSN: 1471-0056 (ISSN-L)
1471-0064
DOI: 10.1038/35066048
OpenAlex: W1598569053
Cited by: 692
References: 79
Citations by year: 2026: 13 · 2025: 17 · 2024: 27 · 2023: 32 · 2022: 16 · 2021: 31 · 2020: 27 · 2019: 28 · 2018: 39 · 2017: 32 · 2016: 33 · 2015: 29 · 2014: 26 · 2013: 35 · 2012: 26
FWCI: 5.59
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Genetics (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: genotype-phenotype correlation, beta-thalassemia, monogenic disorders, genetic modifiers, environmental factors, heritability, complex diseases, gene therapy
MeSH terms: Alleles, Bilirubin, Bone Diseases, Environment, Genes, Dominant, Genes, Recessive, Multigene Family, Genotype, Hemoglobins, Humans, Iron, Mutation, Phenotype, Thalassemia, Genetic Variation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks